Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  allosteric Bcr-Abl tyrosine kinase inhibitor ABL001
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CABL001X2101, NCI-2014-01571, NCT02081378
Start Over